BioMark Diagnostics, Inc. (BUX.CX)

0.45 -0.03 (-6.25%) CAD  |  CNSX  |  Jan 20, 11:19
More

BioMark Diagnostics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for BUX.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Justera Health Ltd. --
Neural Therapeutics, Inc. --
ARCpoint, Inc. --
Biocure Technology, Inc. --
Core One Labs, Inc. --